Summary: At Sleep 2024, Avadel will present new data on Lumryz, the initially extended-launch, when-nightly formulation of sodium oxybate for narcolepsy. Findings highlighted client preference for Lumryz around twice-nightly oxybate, with 94% preferring when-nightly dosing and … [Read more...]
Data Platform Launches to Enhance Hypersomnolence Research | Sleep Review
Summary: A new patient-centric data platform has been launched to enhance research on central disorders of hypersomnolence. This platform, designed to improve understanding of these conditions, uses artificial intelligence and machine learning. The platform allows patients to … [Read more...]
Somnee Overhauls Sleep Headband App with New Data Tools
Summary: Somnee has revamped its app for the smart sleep headband, adding features like brain mapping, sleep journaling, sleep readiness scores, and personalized neurostimulation to enhance sleep quality. Led by new CEO Tim Rosa, the update aims to align the user experience with … [Read more...]
Zevra’s KP1077 Progresses With Positive Phase 2 Data in IH
Summary: In Q1 2024, Zevra Therapeutics claimed constructive topline info from its section 2 research of KP1077 in idiopathic hypersomnia, demonstrating promising tolerance and early indicators of significant advantages. The complete results will be offered at Snooze 2024, and an … [Read more...]
Zevra to Present Data from KP1077 Phase 2 Trial in IH at SLEEP
Summary: At Slumber 2024, Zevra Therapeutics will existing the whole information from the KP1077 section 2 trial for idiopathic hypersomnia, signaling potential progress into stage 3 trials. A shareholder letter from CEO Neil McFarlane underscores this milestone, alongside … [Read more...]
Empatica EmbracePlus Combines Digital Biomarkers with Raw Sleep-Wake Data
The EmbracePlus by Empatica is a health-related wearable that contains actigraphy and over and above. Its added abilities incorporate electronic skin temperature readings. The EmbracePlus is cleared by the US Food stuff and Drug Administration (Food and drug administration) for … [Read more...]
Centessa on Track to Unveil ORX750 Data for Sleep Disorders
Essential Takeaways: Centessa Prescribed drugs claimed development in its orexin agonist software, spotlighting the possible of ORX750 to treat narcolepsy and other rest-wake diseases centered on promising preclinical details. ORX750 demonstrated usefulness in cutting down … [Read more...]